1. Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis. Issue 1 (December 2015) Authors: Buysman, Erin; Chow, Wing; Henk, Henry; Rupnow, Marcia Journal: BMC endocrine disorders Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real-world 12-month outcomes of patients with type 2 diabetes mellitus (T2DM) treated with canagliflozin in a US managed care setting. (October 2016) Authors: Chow, Wing; Buysman, Erin; Rupnow, Marcia; Anderson, Amy; Henk, Henry; Fegade, Mayuresh Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world evaluation of weight loss in patients with T2DM treated with canagliflozin (CANA) – An electronic health-record (EHR)-based study. (October 2016) Authors: Lefebvre, Patrick; Chow, Wing; Pilon, Dominic; Emond, Bruno; Lafeuille, Marie-Hélène; Pfeifer, Michael; Rupnow, Marcia; Duh, Mei Sheng; Fegade, Mayuresh Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗